Skip to main content
SpringerLink
Log in

Liver

  • Chapter
  • First Online:
Gastroenterology and Hepatology

  • 71 Accesses

Abstract

Clinically relevant macroscopic and microscopic anatomy of the liver and nutrient metabolism in the liver have been discussed. This chapter includes focussed discussion on various aetiologies of liver cirrhosis, management of liver failure and portal hypertension, and acute liver failure management. Recent advances in the treatment of chronic viral hepatitis, fatty liver, and hepatocellular carcinoma have been covered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Adeva MM, Souto G, Blanco N, Donapetry C. Ammonium metabolism in humans. Metabolism. 2012;61:1495–511.

    Article  CAS  PubMed  Google Scholar 

  • Bacon BR, et al. Hemochromatosis. In: Feldman M, et al., editors. Sleisinger and Fordtran’s gastrointestinal and liver disease. 9th ed. Philadelphia, PA: Saunders; 2010.

    Google Scholar 

  • Bartenschlager R. The hepatitis C virus replicon system: from basic research to clinical application. J Hepatol. 2005;43:210–6.

    Article  CAS  PubMed  Google Scholar 

  • Beg M, Gupta A. Hepatopulmonary syndrome: a clinical view. Med Update. 2008;99:748–51.

    Google Scholar 

  • Bharadwaj S, et al. Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep. 2016;4(4):272–80.

    Google Scholar 

  • Bowlus CS, Pockros PJ, Kremer EA, et al. Long term obeticholic acid improves histological endpoints in patients with primary biliary cholangitis. Clin Gastroenterol Hepatol. 2020;18:1170–8.

    Article  CAS  PubMed  Google Scholar 

  • CDC. CDC recommendations. MMWR. 2006;55(RR16):30–1.

    Google Scholar 

  • Collins JC, Sarfeh IJ. Surgical management of portal hypertension. West J Med. 1995;162:527–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Dhakshinamoorthy G, et al. Imaging features of fibrolamellar hepatocellular carcinoma. Am J Roentgenol. 2014;202:544–52.

    Article  Google Scholar 

  • Ferraioli G, Wong VW, Castera L, Berzigotti A, Sporea I, Dietrich CF, Choi BI, Wilson SR, Kudo M, Barr RG. Liver ultrasound elastography: an update to the World Federation for Ultrasound in Medicine and Biology guidelines and recommendations. Ultrasound Med Biol. 2018;44(12):2419–40.

    Article  PubMed  Google Scholar 

  • Guu TSY, et al. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A. 2009;106(31):12992–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hancharoenthana W, Leelahavanichkul A. Acute kidney injury spectrum in patients with chronic liver disease: where do we stand? World J Gastroenterol. 2019;25(28):3684–703.

    Article  Google Scholar 

  • Harris AG. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut. 1994;Suppl 3:S1–4.

    Article  Google Scholar 

  • Hemochromatosis. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/dci/Diseases/hemo/hemo_all.html.

  • Hemochromatosis. National Institute of Diabetes and Digestive and Kidney Diseases. http://digestive.niddk.nih.gov/ddiseases/pubs/hemochromatosis/index.htm.

  • Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004;363:1461–8.

    Article  PubMed  Google Scholar 

  • Hohenester S, Oude-Elferink RPJ, Beuers U. Primary biliary cirrhosis. Semin Immunopathol. 2009;31(3):283–307.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med. 2012;367(13):1237–44.

    Article  CAS  PubMed  Google Scholar 

  • Jain MR, Giri SR, Bhoi B, et al. Dual PPAR alpha/gamma agonis Saroglitazar improves liver histopathology and biochemistry in experimental NASH models. Liver Int. 2018;38:1084–94.

    Article  CAS  PubMed  Google Scholar 

  • Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol. 2013;14(10):996–1006.

    Article  CAS  PubMed  Google Scholar 

  • Kaul U, Parmar D, Manjunath K, et al. New dual peroxisome proliferator activated receptor agonist Saroglitazar in diabetic dyslipidemia and non alcoholic fatty liver diseases: integrated analyses of real world evidence. Cardiovasc Diabetol. 2019;18:80.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kim CW, Chang K-M. Hepatitis C virus: virology and life cycle. Clin Mol Hepatol. 2013;19:17–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kordes C, Haussainger D. Hepatic stem cell niches. J Clin Investig. 2013;123(5):1874–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kowdley KV, Vuppalanchi R, Levy C, et al. A randomised, placebo controlled, phase II study of obeticholic acid for primary sclerosis cholangitis. J Hepatol. 2020;73:94–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kubes P, Jenne C. Immune responses in the liver. Annu Rev Immunol. 2018;36:9.1–9.31.

    Article  Google Scholar 

  • Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology. 2012;143:1158–72.

    Article  CAS  PubMed  Google Scholar 

  • Kumar A, Sharma P, Sarin SK. Hepatic venous pressure gradient measurement: time to learn! Indian J Gastroenterol. 2008;27(2):74–80.

    PubMed  Google Scholar 

  • Kumar R, Anand U, Priyadarshi RN. Liver transplantation in acute liver failure: dilemmas and challenges. World J Transplant. 2021;11(6):187–202.

    Article  PubMed  PubMed Central  Google Scholar 

  • Landes Bioscience. Artificial and bioartificial liver support. Organogenesis. 2007;3(1):20–4.

    Article  Google Scholar 

  • Leida Z, Peng H, Xi C, Ping B. Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced-stage hepatocellular carcinoma: a meta-analysis. 2014;9(6):e100305.

    Google Scholar 

  • Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5 Suppl):S13–21.

    Article  CAS  PubMed  Google Scholar 

  • Loosen SH, et al. Role of circulating miRNAs in liver diseases. World J Hepatol. 2017;9(12):586–94.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lurie Y, et al. Non-invasive diagnosis of liver fibrosis. World J Gasroenterol. 2015;21(41):11567–83.

    Article  CAS  Google Scholar 

  • Mannan AASR. Chronic hepatitis—general. Pathology. http://www.pathologyoutlines.com/topic/liverchronichepgeneral.html. Accessed 17 Apr 2018.

  • Marconi L, Haibo B, et al. Functional and structural features of cholangiocytes in health and disease. Cell Mol Gastroenterol Hepatol. 2015;1:368–80.

    Article  Google Scholar 

  • Masakatsu T, Takamichi M. Surgical and locoregional therapy of HCC: TACE. Liver Cancer. 2015;4:165–75.

    Article  Google Scholar 

  • McManus DP, Gray DJ, Yang Y. Diagnosis, treatment, and management of echinococcosis. BMJ. 2012:344, e3866. https://doi.org/10.1136/bmj.e3866.

  • Murali AR, Kotwal V, Chawla S. Chronic hepatitis E: a brief review. World J Hepatol. 2015;7(19):2194–201.

    Article  PubMed  PubMed Central  Google Scholar 

  • Nagral A, et al. Wilson’s disease: clinical practice guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. J Clin Exp Hepatol. 2019;9(1):74–98.

    Article  PubMed  Google Scholar 

  • Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH. Linking pathogenic mechanisms of alcoholic liver disease with clinical phenotypes. Gastroenterology. 2016;150:1756–68.

    Article  CAS  PubMed  Google Scholar 

  • Neuschwander-Tetri BA, Loompa R, Sanyal AJ, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic non alcoholic steatohepatitis (FLINT): a multi centre, randomised, placebocontroleld trial. Lancet. 2015;385:956–65.

    Article  CAS  PubMed  Google Scholar 

  • Nevens F, Andreone P, Mazzella G, et al. A placebo-controlle trial of obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016;375:631–43.

    Article  CAS  PubMed  Google Scholar 

  • Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014;58(5):515–23. https://doi.org/10.4103/0019-5049.14464.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Priyanka R, et al. Interferons and interferon therapy. J Pharm Sci Res. 2014;6(12):400–3.

    Google Scholar 

  • Rena NMRA, Wibawa IDN. Albumin infusion in liver cirrhotic patients. Acta Med Indones. 2010;42:162–7.

    PubMed  Google Scholar 

  • Ripoll C, Groszmann R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133(2):481–8.

    Article  CAS  PubMed  Google Scholar 

  • Rizvon MK, et al. Surgery in patients with liver disease. Med Clin North Am. 2003;87:211–27.

    Article  PubMed  Google Scholar 

  • Roche Pharmaceuticals. Medication guide has been approved by the U.S. Food and Drug Administration. 2002. https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21511_Copegus_lbl.pdf.

  • Russo RA, Vernuccio F. One, no one and one hundred thousand: the wide spectrum of hepatic cystic lesions—tips and tricks for differential diagnosis. EPOS. https://doi.org/10.26044/ecr2019/C-0923.

  • Sarin SK, Sharma M, Koradia P, et al. A prospective, multi-centre, double-blind randomised trial of Saroglitazar 4 mg compared to placebo in patients with non-alcoholic steatohepatitis. Abstract #1427; APDW 2020.

    Google Scholar 

  • Shayto RH, Abou Mrad R, Sharara AI. Use of rifaximin in gastrointestinal and liver diseases. World J Gastroenterol. 2016;22(29):6638–51. https://doi.org/10.3748/wjg.v22.i29.6638.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Solá S, Aranha MM, Steer CJ, Cecília MP. Rodrigues game and players: mitochondrial apoptosis and the therapeutic potential of ursodeoxycholic acid. Curr Issues Mol Biol. 2007;9(2):123–38.

    PubMed  Google Scholar 

  • Sureka B, Rastogi A, Bihari C, Bharathy KGS, Sood V, Alam S. Imaging in ductal plate malformations. Indian J Radiol Imaging. 2017;27(1):6–12. https://doi.org/10.4103/0971-3026.202966.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tajiri K, Shimizu Y. Branched-chain amino acids in liver diseases. Transl Gastroenterol Hepatol. 2018;3:47–58.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tan HK. Molecular adsorbent recirculation system (MARS). Ann Acad Med Singap. 2004;33(3):329–35.

    Article  CAS  PubMed  Google Scholar 

  • Terrault NA, Levy MT, Cheung KW, et al. Viral hepatitis and pregnancy. Nat Rev Gastroenterol Hepatol. 2021;18:117–30. https://doi.org/10.1038/s41575-020-00361-w.

    Article  PubMed  Google Scholar 

  • UDCA. Drug monograph. http://www.mdconsult.com/das/pharm/body/192066773-5/975800014/full/1617.

  • United Healthcare Commercial Medical Benefit Drug Policy. Somatostatin analogues. 2018. https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/somatostatin-analogs.pdf.

  • Venkatanarshimha N, Thomas R, Atmstrong EM, Shirley JF, Fox BM, Jackson SA. Imaging features of duct plate malformations in adults. Clin Radiol. 2011;66:1086–93.

    Article  Google Scholar 

  • Yin C, Evason KJ, Asahina K, Stainier YR. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Investig. 2013;123(5):1902–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Younossi ZM, Ratziu V, Loomba R, et al. OBeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multi centre, randomised, placebo-controlled phase 3 trial. Lancet. 2019;394:2184–96.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology & Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar, India

    A. C. Anand

Authors
  1. A. C. Anand
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Gastroenterology and Hepato-biliary Sciences, Fortis Memorial Research Institute, Gurgaon, Haryana, Haryana, India

    Gourdas Choudhuri

  2. Gastroenterology and Hepatology, KIIT University, Bhubneshwar, Odisha, India

    Anil C Anand

  3. Gatroenterology, Apollo Hospitals, Chennai, Tamil Nadu, India

    P Piramanayagam

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Anand, A.C. (2024). Liver. In: Choudhuri, G., Anand, A.C., Piramanayagam, P. (eds) Gastroenterology and Hepatology. Springer, Singapore. https://doi.org/10.1007/978-981-99-9287-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-9287-4_5

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-9286-7

  • Online ISBN: 978-981-99-9287-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation